Abstract:Background Hepatocellular carcinoma (HCC) has a poor prognosis, often characterized by microvascular invasion (MVI). Radiomics and habitat imaging offer potential for preoperative MVI assessment. Purpose To identify MVI in HCC by habitat imaging, tumor radiomic analysis, and peritumor habitat‐derived radiomic analysis. Study Type Retrospective. Subjects Three hundred eighteen patients (53 ± 11.42 years old; male = 276) with pathologically confirmed HCC (training:testing = 224:94). Field Strength/Sequence 1.5 T, T2WI (spin echo), and precontrast and dynamic T1WI using three‐dimensional gradient echo sequence. Assessment Clinical model, habitat model, single sequence radiomic models, the peritumor habitat‐derived radiomic model, and the combined models were constructed for evaluating MVI. Follow‐up clinical data were obtained by a review of medical records or telephone interviews. Statistical Tests Univariable and multivariable logistic regression, receiver operating characteristic (ROC) curve, calibration, decision curve, Delong test, K‐M curves, log rank test. A P‐value less than 0.05 (two sides) was considered to indicate statistical significance. Results Habitat imaging revealed a positive correlation between the number of subregions and MVI probability. The Radiomic‐Pre model demonstrated AUCs of 0.815 (95% CI: 0.752–0.878) and 0.708 (95% CI: 0.599–0.817) for detecting MVI in the training and testing cohorts, respectively. Similarly, the AUCs for MVI detection using Radiomic‐HBP were 0.790 (95% CI: 0.724–0.855) for the training cohort and 0.712 (95% CI: 0.604–0.820) for the test cohort. Combination models exhibited improved performance, with the Radiomics + Habitat + Dilation + Habitat 2 + Clinical Model (Model 7) achieving the higher AUC than Model 1–4 and 6 (0.825 vs. 0.688, 0.726, 0.785, 0.757, 0.804, P = 0.013, 0.048, 0.035, 0.041, 0.039, respectively) in the testing cohort. High‐risk patients (cutoff value >0.11) identified by this model showed shorter recurrence‐free survival. Data Conclusion The combined model including tumor size, habitat imaging, radiomic analysis exhibited the best performance in predicting MVI, while also assessing prognostic risk. Evidence Level 3 Technical Efficacy Stage 2

Advances in Assessment of Imaging Examination for Tumor Neoangiogenesis Induced by Hepatocellular Carcinoma

Evaluation of Uterine Tumor Angiogenesis with Quantitative Magnetic Resonance Imaging Perfusion Parameters

Dynamic Contrast-Enhanced Computed Tomography Functional Imaging for the Evaluation of Tumor Angiogenesis in Patients with Lung Carcinoma

Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas

Imaging evaluation of tumor angiogenesis

Quantitative assessment of angiogenesis in hepatocellular carcinomas with contrast-enhanced ultrasonography: preliminary clinical research

The advances of preoperative imaging modalities in predicting microvascular invasion (MVI) in hepatocellular carcinoma

[Hepatocellular Carcinoma and Angiogenesis Imaging Using Synchrotron Radiation].

Quantitative assessment of angiogenesis and blood perfusion of hepatic neoplasmas with contrast-enhanced ultrasonography

Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular Carcinoma

Quantitative evaluation of tumor angiogenesis using ultrasound molecular imaging

Preoperative Assessment of the Transeatheter Embolization of Hepatic Carcinoma by Gemstone Spectral Imaging Angiography

Preoperative prediction of microvascular invasion: new insights into personalized therapy for early-stage hepatocellular carcinoma

Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment

Advanced Imaging Techniques in the Therapeutic Response of Transarterial Chemoembolization for Hepatocellular Carcinoma

Experimenal study on liver tumor angiogenesis with contrast-enhanced sonography

Research progresses of imaging studies on preoperative prediction of microvascular invasion of hepatocellular carcinoma.

Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer

Imaging Evaluation of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma

Preoperative Prediction Power of Imaging Methods for Microvascular Invasion in Hepatocellular Carcinoma: A Systemic Review and Meta-Analysis

The Association Between Tumor Radiomic Analysis and Peritumor Habitat‐Derived Radiomic Analysis on Gadoxetate Disodium‐Enhanced MRI With Microvascular Invasion in Hepatocellular Carcinoma